Episode 147 - Top 5 Papers of 2025

Send us Fan Mail Welcome back Rounds Table Listeners! In our year-end episode, Drs. Mike and John Fralick discuss five important research studies published in 2025: Apixaban for Extended Treatment of Provoked Venous Thromboembolism (HI-PRO) (0:00 – 4:20) Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity (SUMMIT) (4:21 – 9:30) Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC) (9:31 – 15:03) Liberal fluid intake versus fluid restriction in chronic heart failure: a randomized clinical trial (FRESH-UP) (15:04 – 18:09) Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis (ESSENCE) (18:10 – 23:49) The Good Stuff (23:50 – 25:27): Toronto Star Santa Claus Fund , Calgary Food Bank , The War Amps Questions? Comments? Feedback? We’d love to hear from you! @roundstable @InternAtWork @MedicinePods

You can listen to Episode 147 - Top 5 Papers of 2025 online on Radio and Podcast. Open the player on this page to stream the available audio.

Episode 147 - Top 5 Papers of 2025 is an episode from The Rounds Table by Dr. John Fralick and Dr. Michael Fralick.

This episode is 25:27 long.

This episode was published on Dec 18, 2025.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from The Rounds Table when more episodes are available from the podcast feed.